Christine Lu MSc, PhD

Christine Lu MSc, PhD is an Associate Professor in the Department of Population Medicine at Harvard Medical School and Harvard Pilgrim Health Care Institute and she co-directs the PRecisiOn Medicine Translational Research (PROMoTeR) Center. She is a pharmacist, health policy scientist and pharmacoepidemiologist. After receiving an MSc (Biopharmaceuticals) and a PhD in Clinical Pharmacology from the University of New South Wales, Australia, Dr. Lu completed her post-doctoral training at Harvard Medical School.
Dr. Lu leads the precision medicine & policy, and precision medicine oncology portfolios for the DPM. Her research focuses on the policy, legal, ethical, economic and societal issues of precision medicine, which have substantial impacts on the coverage and reimbursement and clinical integration of genomic testing and sequencing. She is Co-Principal Investigator of Genomics-based Technologies: Access and Reimbursement Issues.
Dr. Lu co-leads the Genetic and Molecular Tests Data Workgroup for the Cancer Research Network. She is site Principal Investigator of an NCI-funded project to examine organizational and economic barriers and facilitators to the implementation of universal Lynch Syndrome Screening across multiple healthcare systems (Study PI: Alanna Rahm, Geisinger Health). She also conducts research to assess real-world utility of genomic testing and sequencing, including the impact of value-based contracts. Dr. Lu provides intense one-on-one mentorship to PhD students, post-doctoral students, researchers, and mid-career university faculty